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Discrimination
between Highly
Pathogenic and
Low Pathogenic H5
Avian Influenza A
Viruses
To the Editor: To thoroughly
investigate avian influenza outbreaks,
identifying highly pathogenic avian
influenza (HPAI) and low pathogenic
avian influenza (LPAI) is essential.
Currently, determination of inserted
basic amino acids within the hemag-
glutinin cleavage site of HPAI relies
on nucleotide sequencing (1–3).
Direct sequencing is relatively time-
consuming and laborious and thus is
not suitable for local and regional
diagnostic laboratories that receive
large numbers of samples that may
contain HPAI or LPAI subtype H5N1.
Therefore, a rapid diagnostic assay
was developed to discriminate
between HPAI and LPAI subtype H5
viruses by 1-step real-time reverse
transcription–polymerase chain reac-
tion (RT-PCR) with melting curve
analysis. 
H5 primers flanking the cleavage
site were designed from conserved
regions among HPAI and LPAI strains
by using nucleotide sequences
obtained from GenBank and our pre-
vious studies (4–6). The primers con-
sisted of a forward primer H5F3+
(nucleotides 1001–1021: 5′-AACA-
GATTAGTCCTTGCGACTG-3′) and
a reverse primer H5R2+ (nucleotides
1124–1103: 5′-CATCTACCATTCC-
CTGCCATCC-3′), which yielded
products of ≈124 bp and ≈112 bp, cor-
responding to HPAI and LPAI,
respectively. Consequently, the sizes
of the amplicons and percentage gua-
nine-cytosine content were different,
allowing discrimination between
HPAI and LPAI by melting curve
analysis (7). 
One-step, real-time RT-PCR with
melting curve analysis was performed
in an ABI 7500 system (Applied
Biosystems, Foster City, CA, USA).
In each reaction, 3.0 µL of RNA sam-
ple was combined with a reaction
mixture containing 10 µL 2× SYBR
Green PCR Master Mix (Applied
Biosystems), 0.5 µL 40× MultiScribe
(Applied Biosystems) and RNase
inhibitor, each primer (at final con-
centration of 0.5 µmol/L), 1.5
mmol/LMgCl2, and RNase-free water
in a final volume of 20 µL. The ther-
mal profile began with incubation at
48°C for 45 min (reverse transcrip-
tion), then incubation at 95°C for 10
min (predenaturation), followed by 40
cycles of amplification alternating
between 94°C for 15 s (denaturation)
and 68°C for 40 s (annealing/exten-
sion). The SYBR Green I fluorescent
signal was obtained once per cycle at
the end of the extension step. After
amplification, melting curve analysis
was performed by heating the sample
to 95°C for 15 s, then cooling it to
70°C for 1 min, followed by a linear
temperature increase to 95°C at a rate
of 0.5°C/s, while continuously moni-
toring the fluorescent signal. Data
were analyzed by the 7500 System
SDS Software version 1.2 (Applied
Biosystems).
To develop the assay, samples pre-
viously identified as influenza
A/chicken/Nakorn-Patom/Thailand/
CU-K2/04 (H5N1) served as a control
for HPAI, and A/duck/Hong Kong
Special Administrative Region,
People’s Republic of China/308/78
(H5N3) served as a control for LPAI.
The H5 genes (nucleotides 914–1728)
of each strain were inserted into
pGEM-T Easy Vector and then tran-
scribed in vitro by using RiboMAX
Large Scale RNAProduction System-
T7 (Promega, Madison, WI, USA).
Serial 10-fold dilutions of the stan-
dard H5 RNAwere subjected to a sen-
sitivity test (8). The fluorescent signal
can be detected at RNA dilutions as
low as 102 copies/µL. To assess the
specificity, viral RNA extracted from
other subtypes of influenza A viruses
(H1–H4 and H6–H15) was tested.
The assay was specific for the H5 sub-
type, since no amplification was
detected from other subtypes. 
Three preliminary melting curve
analyses showed that this assay was
effective in discriminating between
the melting peaks of HPAI and LPAI
(Figure). The variations of melting
temperature (Tm) between runs were
experimentally determined. The mean
(standard deviation) of Tm values for
HPAI and LPAI were 77.43°C
(0.21°C) and 79.57°C (0.23°C),
respectively. This assay provided high
reliability and reproducibility, since
the coefficients of variation were
<0.30.
Seventy-eight specimens of
influenza Avirus were used to validate
the assay. The 75 HPAI samples were
isolated during the 2004 outbreak in
Thailand; 3 LPAI samples, including
A/avian/NY/01 (H5N2), A/Chicken/
Mexico/31381–3/94 (H5N2), and
A/shoveler/Egypt/03 (H5N2), were
provided by the Centers for Disease
Control and Prevention. The viruses
were isolated in embryonated chickenLETTERS
eggs as described previously (9).
RNA was extracted from 140 µLo f
allantoic fluid, and RT-PCR was per-
formed as described above. Melting
curve analysis showed that all H5N1
isolates from the 2004 outbreak in
Thailand were interpreted as HPAI,
whereas the 3 samples of H5N2 sub-
type were classified as LPAI. The Tm
varied from 77.2°C to 78.1°C for
HPAI and 78.75°C to 79.5°C for
LPAI. The melting curve analysis
results were completely concordant
with the results of direct sequence
analysis of the H5 gene for all sam-
ples tested. 
The melting curve analysis
described here provides a rapid, accu-
rate, and high-throughput approach to
discriminate between HPAI and LPAI.
This assay is particularly attractive for
large-scale screening of suspected
subtype H5 influenza A virus during
outbreaks to identify candidate LPAI
that could be used as vaccine strains. 
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Figure. Discrimination between highly pathogenic avian influenza (HPAI) and low patho-
genic avian influenza (LPAI) by melting curve analysis based on real-time reverse tran-
scription–polymerase chain reaction of the H5 HA gene with SYBR Green I fluorescent
dye. The melting peaks of HPAI and LPAI were clearly separated. The cutoff value was
set at 78.50°C (midpoint between HPAI and LPAI) and used to interpret the pathogenicity
of unknown samples.